07:17 AM EST, 11/12/2025 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q3 adjusted net loss Wednesday of $0.05 per diluted share, compared with a loss of $0.11 a year earlier.
Revenue for the quarter ended Sept. 30 was $272.3 million, compared with $160.2 million a year earlier.
Analysts polled by FactSet expected $274.4 million.